Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Heidi D Klepin Aaron T Gerds Richard F Little Roland B Walter Mark R Litzow Jeffrey E Lancet |
| Publication date | December 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |